UCLA Obstetrics and Gynecology has expanded our educational program to include a new fellowship that harnesses the research expertise of our department and UCLA Urology’s Health Services research group. The UCLA Patient-Centered Outcomes Research Training in Urologic and Gynecologic Cancers (PCORT UroGynCan) is a T32 mentored training program that prepares postdoctoral scholars for research careers focused on scientific innovations that improve the design, delivery, and outcomes of urologic and/or gynecologic cancer care at the individual, population, and health care system levels.
Through mentored training and career development of the next generation of interdisciplinary leaders in health services and patient-centered outcomes research, UCLA’s PCORT UroGynCan T32 program seeks to increase the pace and volume of scientific discovery and innovation in the diagnosis, treatment, and prevention of urologic and gynecologic cancers and advance our knowledge of delivery and implementation strategies for proven interventions in real-world practice and community settings.
In closing the gap between evidence-based interventions and their uptake across diverse health services settings and populations, including historically underserved populations, this training program seeks to improve health system performance and optimize outcomes and health-related quality of life for patients and their families.
The PCORT UroGynCan fellowship, funded by the National Institutes of Health, will commence with the 2021-22 academic year and will support four postdoctoral trainees per year, each for a 2-year appointment. The Principal Investigators and Program Directors are Deborah Krakow, MD, Professor and Chair of UCLA Obstetrics and Gynecology and Mark S. Litwin, MD, MPH, Professor and Chair of UCLA Urology.
For more information, please visit our program website.